Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy

Lu Tang,1,2,* Yijun Mei,1,2,* Yan Shen,1,2,* Shun He,1,2 Qiaqia Xiao,1,2 Yue Yin,1,2 Yonggang Xu,3 Jie Shao,3 Wei Wang,1,2 Zihao Cai3 1State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tang L, Mei Y, Shen Y, He S, Xiao Q, Yin Y, Xu Y, Shao J, Wang W, Cai Z
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/cad9aec29bce4c5b835d5a47be595bf0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cad9aec29bce4c5b835d5a47be595bf0
record_format dspace
spelling oai:doaj.org-article:cad9aec29bce4c5b835d5a47be595bf02021-12-02T16:39:48ZNanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy1178-2013https://doaj.org/article/cad9aec29bce4c5b835d5a47be595bf02021-08-01T00:00:00Zhttps://www.dovepress.com/nanoparticle-mediated-targeted-drug-delivery-to-remodel-tumor-microenv-peer-reviewed-fulltext-article-IJNhttps://doaj.org/toc/1178-2013Lu Tang,1,2,* Yijun Mei,1,2,* Yan Shen,1,2,* Shun He,1,2 Qiaqia Xiao,1,2 Yue Yin,1,2 Yonggang Xu,3 Jie Shao,3 Wei Wang,1,2 Zihao Cai3 1State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People’s Republic of China; 2NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, 210009, People’s Republic of China; 3Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, People’s Republic of China*These authors contributed equally to this workCorrespondence: Wei WangState Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People’s Republic of ChinaTel +86-25-83271102Email wangcpu209@cpu.edu.cnZihao CaiDepartment of General Surgery, Huashan Hospital, Fudan University, No. 12 Middle Urumqi Road, Shanghai, 200040, People’s Republic of ChinaTel +86-21-66895079Email davidcai1@163.comAbstract: Advanced research has revealed the crucial role of tumor microenvironment (TME) in tumorigenesis. TME consists of a complicated network with a variety of cell types including endothelial cells, pericytes, immune cells, cancer-associated fibroblasts (CAFs), cancer stem cells (CSCs) as well as the extracellular matrix (ECM). The TME-constituting cells interact with the cancerous cells through plenty of signaling mechanisms and pathways in a dynamical way, participating in tumor initiation, progression, metastasis, and response to therapies. Hence, TME is becoming an attractive therapeutic target in cancer treatment, exhibiting potential research interest and clinical benefits. Presently, the novel nanotechnology applied in TME regulation has made huge progress. The nanoparticles (NPs) can be designed as demand to precisely target TME components and to inhibit tumor progression through TME modulation. Moreover, nanotechnology-mediated drug delivery possesses many advantages including prolonged circulation time, enhanced bioavailability and decreased toxicity over traditional therapeutic modality. In this review, update information on TME remodeling through NPs-based targeted drug delivery strategies for anticancer therapy is summarized.Keywords: tumor microenvironment, nanotherapeutics, cancer treatment, targeted delivery, regulation strategyTang LMei YShen YHe SXiao QYin YXu YShao JWang WCai ZDove Medical Pressarticletumor microenvironmentnanotherapeuticscancer treatmenttargeted deliveryregulation strategyMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 5811-5829 (2021)
institution DOAJ
collection DOAJ
language EN
topic tumor microenvironment
nanotherapeutics
cancer treatment
targeted delivery
regulation strategy
Medicine (General)
R5-920
spellingShingle tumor microenvironment
nanotherapeutics
cancer treatment
targeted delivery
regulation strategy
Medicine (General)
R5-920
Tang L
Mei Y
Shen Y
He S
Xiao Q
Yin Y
Xu Y
Shao J
Wang W
Cai Z
Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy
description Lu Tang,1,2,* Yijun Mei,1,2,* Yan Shen,1,2,* Shun He,1,2 Qiaqia Xiao,1,2 Yue Yin,1,2 Yonggang Xu,3 Jie Shao,3 Wei Wang,1,2 Zihao Cai3 1State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People’s Republic of China; 2NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, 210009, People’s Republic of China; 3Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, People’s Republic of China*These authors contributed equally to this workCorrespondence: Wei WangState Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People’s Republic of ChinaTel +86-25-83271102Email wangcpu209@cpu.edu.cnZihao CaiDepartment of General Surgery, Huashan Hospital, Fudan University, No. 12 Middle Urumqi Road, Shanghai, 200040, People’s Republic of ChinaTel +86-21-66895079Email davidcai1@163.comAbstract: Advanced research has revealed the crucial role of tumor microenvironment (TME) in tumorigenesis. TME consists of a complicated network with a variety of cell types including endothelial cells, pericytes, immune cells, cancer-associated fibroblasts (CAFs), cancer stem cells (CSCs) as well as the extracellular matrix (ECM). The TME-constituting cells interact with the cancerous cells through plenty of signaling mechanisms and pathways in a dynamical way, participating in tumor initiation, progression, metastasis, and response to therapies. Hence, TME is becoming an attractive therapeutic target in cancer treatment, exhibiting potential research interest and clinical benefits. Presently, the novel nanotechnology applied in TME regulation has made huge progress. The nanoparticles (NPs) can be designed as demand to precisely target TME components and to inhibit tumor progression through TME modulation. Moreover, nanotechnology-mediated drug delivery possesses many advantages including prolonged circulation time, enhanced bioavailability and decreased toxicity over traditional therapeutic modality. In this review, update information on TME remodeling through NPs-based targeted drug delivery strategies for anticancer therapy is summarized.Keywords: tumor microenvironment, nanotherapeutics, cancer treatment, targeted delivery, regulation strategy
format article
author Tang L
Mei Y
Shen Y
He S
Xiao Q
Yin Y
Xu Y
Shao J
Wang W
Cai Z
author_facet Tang L
Mei Y
Shen Y
He S
Xiao Q
Yin Y
Xu Y
Shao J
Wang W
Cai Z
author_sort Tang L
title Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy
title_short Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy
title_full Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy
title_fullStr Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy
title_full_unstemmed Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy
title_sort nanoparticle-mediated targeted drug delivery to remodel tumor microenvironment for cancer therapy
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/cad9aec29bce4c5b835d5a47be595bf0
work_keys_str_mv AT tangl nanoparticlemediatedtargeteddrugdeliverytoremodeltumormicroenvironmentforcancertherapy
AT meiy nanoparticlemediatedtargeteddrugdeliverytoremodeltumormicroenvironmentforcancertherapy
AT sheny nanoparticlemediatedtargeteddrugdeliverytoremodeltumormicroenvironmentforcancertherapy
AT hes nanoparticlemediatedtargeteddrugdeliverytoremodeltumormicroenvironmentforcancertherapy
AT xiaoq nanoparticlemediatedtargeteddrugdeliverytoremodeltumormicroenvironmentforcancertherapy
AT yiny nanoparticlemediatedtargeteddrugdeliverytoremodeltumormicroenvironmentforcancertherapy
AT xuy nanoparticlemediatedtargeteddrugdeliverytoremodeltumormicroenvironmentforcancertherapy
AT shaoj nanoparticlemediatedtargeteddrugdeliverytoremodeltumormicroenvironmentforcancertherapy
AT wangw nanoparticlemediatedtargeteddrugdeliverytoremodeltumormicroenvironmentforcancertherapy
AT caiz nanoparticlemediatedtargeteddrugdeliverytoremodeltumormicroenvironmentforcancertherapy
_version_ 1718383600574922752